C07D 215/22
Attached in position 2 or 4
Official title: attached in position 2 or 4
C07D215/22 (Attached in position 2 or 4) appears on 1,395 US grants and 1,295 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,395
- Published applications
- 1,295
- Assignees
- 692
- Inventors
- 4,532
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 16 | 0 |
| 1977 | 22 | 0 |
| 1978 | 7 | 0 |
| 1979 | 9 | 0 |
| 1980 | 16 | 0 |
| 1981 | 18 | 0 |
| 1982 | 19 | 0 |
| 1983 | 20 | 0 |
| 1984 | 18 | 0 |
| 1985 | 18 | 0 |
| 1986 | 22 | 0 |
| 1987 | 13 | 0 |
| 1988 | 23 | 0 |
| 1989 | 22 | 0 |
| 1990 | 19 | 0 |
| 1991 | 21 | 0 |
| 1992 | 20 | 0 |
| 1993 | 41 | 0 |
| 1994 | 30 | 0 |
| 1995 | 36 | 0 |
| 1996 | 28 | 0 |
| 1997 | 27 | 0 |
| 1998 | 23 | 0 |
| 1999 | 18 | 0 |
| 2000 | 20 | 0 |
| 2001 | 17 | 2 |
| 2002 | 16 | 27 |
| 2003 | 23 | 42 |
| 2004 | 21 | 56 |
| 2005 | 27 | 61 |
| 2006 | 38 | 66 |
| 2007 | 21 | 59 |
| 2008 | 25 | 42 |
| 2009 | 46 | 57 |
| 2010 | 36 | 73 |
| 2011 | 48 | 52 |
| 2012 | 48 | 56 |
| 2013 | 54 | 56 |
| 2014 | 48 | 76 |
| 2015 | 64 | 55 |
| 2016 | 31 | 61 |
| 2017 | 52 | 53 |
| 2018 | 36 | 55 |
| 2019 | 36 | 43 |
| 2020 | 37 | 48 |
| 2021 | 29 | 51 |
| 2022 | 28 | 30 |
| 2023 | 23 | 58 |
| 2024 | 21 | 45 |
| 2025 | 27 | 46 |
| 2026 | 17 | 25 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Membrane-active anti-bacterial compounds and uses thereof29 Sep 2026US 12,747,213 B2Regents of the University of Minnesota
- GluN2B-subunit selective antagonists of the N-methyl-D-aspartate receptors with enhanced potency at acidic pH29 Sep 2026US 12,747,221 B2Emory Univeristy
- Cabozantinib compositions and methods of use22 Sep 2026US 12,741,938 B2Handa Oncology, LLC
- Mitochondrial ATP inhibitors targeting the gamma subunit prevent metastasis1 Sep 2026US 12,723,029 B2Lunella Biotech, Inc.
- Chiral bimetallic cooperative catalysis system containing chelating ligand and use thereof in asymmetric synthesis of bedaquiline16 Jun 2026US 12,654,154 B2Shanghai Jiao Tong University
- Crystalline forms of 3-(5,7-difluoro-4-oxo-1,4-dihydroquinolin-2-yl)-4-(methylsulfonyl)benzonitrile8 Oct 2026US 2026/0308126 A1
- Heterocyclic derivatives, compositions and uses thereof17 Sep 2026US 2026/0274799 A1Danatlas Pharmaceuticals Co., Ltd.
- A method for synthesizing aryl ethers ortho-substituted to the nitrogen atom of n-heterocycles3 Sep 2026US 2026/0257997 A1Xinjiang University
- Polycyclic thyroid hormone beta receptor agonist and use thereof20 Aug 2026US 2026/0242350 A1Cascade Pharmaceuticals, Inc.
- Naphthylamide compound, and preparation method therefor and use thereof30 Jul 2026US 2026/0216169 A1Shenzhen Chipscreen Biosciences Co., Ltd.
Most cited
By later US patents
- Cyclic-substituted unsymmetrical cyanine dyes371US 5,436,134 AMolecular Probes, Inc. · 1995
- Fused cycloalkylimidazopyridines299US 5,352,784 AMinnesota Mining and Manufacturing Company · 1994
- Process for preparing quinoline amines240US 5,395,937 AMinnesota Mining and Manufacturing Company · 1995
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase226US 5,480,883 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1996
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase209US 5,409,930 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1995